Dare Bioscience Inc DARE

Healthcare Biotechnology

Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial vaginosis in females 12 years of age and older. Its other product candidates include Ovaprene, Sildenafil Cream, and DARE-HRT1. Ovaprene is an investigational, hormone-free, monthly intravaginal contraceptive. Sildenafil Cream is a novel cream formulation of sildenafil for the treatment of female sexual arousal disorder; and DARE-HRT1 is an intravaginal ring designed to deliver a combination of menopausal hormone therapy, bio-identical 17b-estradiol and progesterone together, continuously over a 28-day period for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes.

NDAQ:DARE - Post by User

Dare Bioscience Inc

<< Previous

Bullboard Posts

Next >>

(488)
•••

Post by Chefboy69on Nov 15, 2021 1:27pm

101 Views

Post# 34128050

its climbing

FDA approval will be announced in 4 weeks.

pharma stocks ALWAYS move up before,

get in early. Make your money back and keep the rest on the table

that is what i do

Good luck all

<< Previous

Bullboard Posts

Next >>

A junior miner and long-term compounder to invest in gold's resurgence